Susquehanna International Group’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-31,200
| Closed | -$141K | – | 12208 |
|
|
2025
Q3 | $141K | Buy |
+31,200
| New | +$92K | ﹤0.01% | 11325 |
|
|
2022
Q2 | – | Sell |
-5,580
| Closed | -$73K | – | 12781 |
|
|
2022
Q1 | $73K | Sell |
5,580
-1,120
| -17% | -$16.4K | ﹤0.01% | 12099 |
|
|
2021
Q4 | $118K | Sell |
6,700
-32,040
| -83% | -$641K | ﹤0.01% | 12013 |
|
|
2021
Q3 | $841K | Sell |
38,740
-2,470
| -6% | -$63K | ﹤0.01% | 8007 |
|
|
2021
Q2 | $1.44M | Buy |
41,210
+2,650
| +7% | +$143K | ﹤0.01% | 6756 |
|
|
2021
Q1 | $3.8M | Buy |
38,560
+2,210
| +6% | +$265K | ﹤0.01% | 4454 |
|
|
2020
Q4 | $3.94M | Buy |
36,350
+28,430
| +359% | +$3.52M | ﹤0.01% | 3837 |
|
|
2020
Q3 | $816K | Buy |
7,920
+2,170
| +38% | +$325K | ﹤0.01% | 6617 |
|
|
2020
Q2 | $1.2M | Buy |
5,750
+2,640
| +85% | +$468K | ﹤0.01% | 5498 |
|
|
2020
Q1 | $304K | Sell |
3,110
-26,230
| -89% | -$3.06M | ﹤0.01% | 7948 |
|
|
2019
Q4 | $3.38M | Sell |
29,340
-20,450
| -41% | -$1.8M | ﹤0.01% | 3516 |
|
|
2019
Q3 | $2.71M | Buy |
+49,790
| New | +$5.61M | ﹤0.01% | 3663 |
|
|
2018
Q4 | – | Sell |
-2,030
| Closed | -$123K | – | 8839 |
|
|
2018
Q3 | $123K | Buy |
2,030
+140
| +7% | +$7.86K | ﹤0.01% | 8516 |
|
|
2018
Q2 | $100K | Sell |
1,890
-5,410
| -74% | -$325K | ﹤0.01% | 9040 |
|
|
2018
Q1 | $423K | Buy |
7,300
+6,060
| +489% | +$377K | ﹤0.01% | 6971 |
|
|
2017
Q4 | $43K | Buy |
+1,240
| New | +$40.8K | ﹤0.01% | 8944 |
|
|
2016
Q3 | – | Sell |
-1,500
| Closed | -$47K | – | 8335 |
|
|
2016
Q2 | $47K | Buy |
1,500
+130
| +9% | +$5.87K | ﹤0.01% | 8253 |
|
|
2016
Q1 | $71K | Sell |
1,370
-540
| -28% | -$30.2K | ﹤0.01% | 8561 |
|
|
2015
Q4 | $182K | Sell |
1,910
-27,070
| -93% | -$2.38M | ﹤0.01% | 8502 |
|
|
2015
Q3 | $2.39M | Buy |
28,980
+12,420
| +75% | +$1.59M | ﹤0.01% | 3924 |
|
|
2015
Q2 | $2.69M | Buy |
16,560
+13,500
| +441% | +$4.55M | ﹤0.01% | 4069 |
|
|
2015
Q1 | $1.24M | Buy |
+3,060
| New | +$1.29M | ﹤0.01% | 5324 |
|
Susquehanna International Group's ADVM Position: Q4 2025 in Review
Susquehanna International Group sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 26,255 shares — an estimated $119K sold.
Susquehanna International Group first reported a position in ADVM in Q1 2015 and held it in 30 quarters. The position peaked at $6.02M in Q1 2015. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Susquehanna International Group reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 26,255 Adverum Biotechnologies shares in Q4 2025, an estimated $119K.
- Susquehanna International Group first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 30 quarters.
- Susquehanna International Group's Adverum Biotechnologies position peaked at $6.02M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.